Navigation Links
Synchrotron radiation illuminates how babies' protective bubble bursts
Date:11/6/2007

Researchers at the University of Reading, School of Pharmacy have developed an important new technique to study one of the most common causes of premature birth and prenatal mortality. The findings are published in the November 7 issue of the online, open-access journal PLoS ONE.

Dr Che Connon, a Research Councils UK Fellow in Stem Cells and Nanomaterials, and his team used a powerful X-ray beam to examine tiny structures within the protective sac - amniotic membrane - which surrounds the developing baby.

This beam can resolve structures far smaller than a light or electron microscope. Furthermore, unlike other more intrusive forms of microscopy, X-ray investigation requires no processing of the tissue before examination, so can produce an accurate measurement of amniotic membrane structure in its normal state.

When the protective sac raptures during labour this is when the mothers waters burst; if premature rupture occurs it can result in death or mental retardation of the child. Currently premature birth is increasing and 40% are attributed to the early rupture of amniotic membranes. Thus, a better understanding of the rupture process will lead to better treatment, earlier diagnosis and fewer premature deliveries

Dr Connon, an expert in tissue structure, said: This is of interest to the general public because amniotic membrane rupture is an important stage in the start of labour. More importantly early rupture of the amniotic membranes occurs in up to 20% of all pregnancies worldwide, and is the most common cause of preterm birth, leading to babies dying or having major problems such as cerebral palsy. The paper describes a new breakthrough in understanding the structure of amniotic membranes and how they rupture. Hopefully this will lead to therapies designed to prevent preterm membrane rupture as well.

Rupture of amniotic sac has been associated with a weakening of the tissue, but there is very little information available concerning the detailed mechanics of how this actually occurs.

We have now identified a regular cross-work arrangement of fibre forming molecules within the amniotic membrane which give the tissue its strength. Furthermore we have detected nanoscale alterations in the molecular arrangement within areas associated with amniotic membrane rupture. These results suggest, for the first time, that it is the loss of this molecular lattice like arrangement that governs the timing of membranes rupture.

Therefore, by controlling the amniotic membranes molecular arrangement we believe we can prevent premature rupture and delivery in the future.


'/>"/>

Contact: Che Connon
c.j.connon@reading.ac.uk
44-118-378-7053
Public Library of Science
Source:Eurekalert

Related biology technology :

1. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
2. YM BIOSCIENCES ANNOUNCES POSITIVE PRELIMINARY RESULTS FROM PHASE I/II LUNG CANCER TRIAL OF NIMOTUZUMAB COMBINED WITH RADIATION
3. Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions
4. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
5. Carrington and DaySpring Pharma Extend and Formalize Agreement for Distribution of Diabetic and Radiation Products Into Physician Market
6. Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... 29, 2017 , ... ComplianceOnline, the leading governance, risk and compliance advisory network ... Device Summit 2017 venue and speaker lineup. The Summit will take place on June ... The Omni Parker House Hotel, which is located at 60 School Street, Boston, MA ...
(Date:3/29/2017)... 2017  Halozyme Therapeutics, Inc. (NASDAQ: HALO), a ... today announced that an Oncologic Drug Advisory Committee ... 11 to 0 that the benefit/risk of rituximab/hyaluronidase ... for patients in the proposed indications of follicular ... leukemia. The FDA action date is June 26, ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... edge instrumentation for cell-based assays, disperses a quarterly travel award to noteworthy scientists ... Today the company announced that its new round of awards are being given ...
(Date:3/29/2017)... ... March 29, 2017 , ... Bactana Animal Health, a company developing natural products ... through enhancement of the gut microbiota, today announced the closing of its first round ... York-based Sustainable Income Capital Management, LLC and a number of private investors. The company ...
Breaking Biology Technology:
(Date:2/28/2017)... , Feb. 28, 2017   Acuant , a ... globally, announces significant enhancements to new and core technologies ... New products include mobile and desktop Acuant FRM TM ... - a real time manual review of identity ... technology provides the fastest and most accurate capture software ...
(Date:2/28/2017)... BARCELONA , Spanien, 27. Februar 2017 /PRNewswire/ ... durch Iris-Scan, wird seine erstklassige biometrische Lösung ... Snapdragon™ 835 mit X16 LTE auf dem ... 2. März) am Qualcomm-Stand in Halle 3, ... 835-Prozessor beinhaltet die Sicherheitsplattform Qualcomm Haven™ – ...
(Date:2/26/2017)... 25, 2017  Securus Technologies, a leading provider ... public safety, investigation, corrections and monitoring, announces the ... "Too often, too many offenders return ... jails are trying to tackle this ongoing problem ... and family members. While significant steps are underway, Securus ...
Breaking Biology News(10 mins):